Tech Company Financing Transactions
Cellumen Funding Round
Cellumen, based in Pittsburgh, secured investment capital from Novitas Capital.
Transaction Overview
Company Name
Announced On
6/20/2005
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Novitas Capital (Paul Schmitt)
Proceeds Purpose
Cellumen is forming discovery partnerships with the pharmaceutical and biotechnology industries using high content screening (HCS) with existing and advanced cell-based reagents and cell lines.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
3180 William Pitt Way
Pittsburgh, PA 15238
USA
Pittsburgh, PA 15238
USA
Phone
Website
Email Address
Overview
Cellumen is a systems cell biology company that is focused on defining the functions of genes, coding and non-coding RNA's, proteins and other cellular constituents that regulate and perform the myriad of functions that define normal life and are related to specific disease processes as potential biomarkers and/or targets for drug discovery and patient profiling.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lansing Taylor
Chief Financial Officer
Gregory Finerty
Chief Scientific Officer
Kenneth Giuliano
Vice President
Albert Gough
Vice President
Patricia Johnston
VP - Bus. Development
Donald Taylor
Browse more venture capital transactions:
Prev: 6/20/2005: Sanovia venture capital transaction
Next: 6/20/2005: Nomis Solutions venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs